284 results on '"Bourboulia, Dimitra"'
Search Results
52. Chemical Perturbation of Oncogenic Protein Folding: from the Prediction of Locally Unstable Structures to the Design of Disruptors of Hsp90–Client Interactions
53. PD64-01 THE STATUS OF THE TUMOR SUPPRESSORS VHL AND CDKN2A IMPACTS CLEAR CELL RENAL CELL CARCINOMA SENSITIVITY TO CDK 4/6 INHIBITORS
54. Kaposi Sarcoma Herpesvirus: Update
55. Mutation of the co-chaperone Tsc1 in bladder cancer diminishes Hsp90 acetylation and reduces drug sensitivity and selectivity
56. Antibodies against human herpesvirus 8 in black South African patients with cancer
57. Short- and long-term effects of highly active antiretroviral therapy on Kaposi sarcoma-associated herpesvirus immune responses and viraemia
58. Seroepidemiology and Molecular Epidemiology of Kaposiʼs Sarcoma-Associated Herpesvirus Among Jewish Population Groups in Israel
59. HHV-8 Peripheral-Blood Viral Load and the Titer of Antibodies against HHV-8
60. Co-chaperones TIMP2 and AHA1 Competitively Regulate Extracellular HSP90:Client MMP2 Activity and Matrix Proteolysis
61. MP05-16 TSC1 EXPRESSION AS A PREDICTIVE BIOMARKER OF BLADDER CANCER RESPONSE TO HSP90 INHIBITORS
62. Post-translational Regulation of FNIP1 Creates a Rheostat for the Molecular Chaperone Hsp90
63. Serologic Evidence for Mother-to-Child Transmission of Kaposi Sarcoma-Associated Herpesvirus Infection
64. Viral coinfections among African children infected with human immunodeficiency virus type 1. (HIV/AIDS: Brief Report)
65. Extracellular HSP90 warms up integrins for an irisin workout.
66. Risk factors for high anti-HHV-8 antibody titers (≥1:51,200) in black, HIV-1 negative South African cancer patients: a case control study
67. Carcinomas of the renal medulla: A comprehensive genomic profiling (CGP) study.
68. PD46-11 PHOSPHORYLATION AND UBIQUITINATION REGULATE PROTEIN PHOSPHATASE-5 ACTIVITY AND ITS PROSURVIVAL ROLE IN KIDNEY CANCER
69. MP88-13 TUMOR SUPPRESSOR TSC1 IS A NEW HSP90 COCHAPERONE THAT FACILITATES FOLDING OF KINASE AND NON-KINASE CLIENTS
70. Tumor suppressor Tsc1 is a new Hsp90 co‐chaperone that facilitates folding of kinase and non‐kinase clients
71. Phosphorylation and Ubiquitination Regulate Protein Phosphatase 5 Activity and Its Prosurvival Role in Kidney Cancer
72. Faculty Opinions recommendation of Extracellular phosphorylation of a receptor tyrosine kinase controls synaptic localization of NMDA receptors and regulates pathological pain.
73. The FNIP co-chaperones decelerate the Hsp90 chaperone cycle and enhance drug binding
74. MP85-13 FNIP CO-CHAPERONES PROTECT THE TUMOR SUPPRESSOR FLCN FROM UBIQUITINATION AND DEGRADATION IN THE PROTEASOME
75. Mps1 Mediated Phosphorylation of Hsp90 Confers Renal Cell Carcinoma Sensitivity and Selectivity to Hsp90 Inhibitors
76. The dynamic interactome of human Aha1 upon Y223 phosphorylation
77. c-Abl Mediated Tyrosine Phosphorylation of Aha1 Activates Its Co-chaperone Function in Cancer Cells
78. Targeting Hsp90 in urothelial carcinoma
79. Abstract B79: TIMP-2 mediated growth inhibition of human glioma U87MG is accompanied by elevated IGFBP7 and FSP-1/S100A4 expression at the tumor/stroma interface
80. Prostate Cancer Biomarkers– A Bench to Bedside Perspective
81. Molecular mechanisms of tissue inhibitor of metalloproteinase 2 in the tumor microenvironment
82. Asymmetric Hsp90 N Domain SUMOylation Recruits Aha1 and ATP-Competitive Inhibitors
83. HHV-8 peripheral-blood viral load and the titer of antibodies against HHV-8
84. TIMP-2 modulates cancer cell transcriptional profile and enhances E-cadherin/beta-catenin complex expression in A549 lung cancer cells
85. Combined inhibition of Wee1 and Hsp90 activates intrinsic apoptosis in cancer cells
86. TIMP-2 Targets Tumor-associated Myeloid Suppressor Cells With Effects in Cancer Immune Dysfunction and Angiogenesis
87. Anti-tumoral Properties of Endogenous Angiogenesis Inhibitors: A Case for Continued TIMP-2 Preclinical Development
88. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion
89. Swe1Wee1-Dependent Tyrosine Phosphorylation of Hsp90 Regulates Distinct Facets of Chaperone Function
90. Kaposi's Sarcoma–Associated Herpesvirus-Encoded Interleukin-6 and G-Protein–Coupled Receptor Regulate Angiopoietin-2 Expression in Lymphatic Endothelial Cells
91. Kaposi Sarcoma Herpesvirus: Update
92. Kaposi sarcoma herpesvirus–induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma
93. Risk factors for high anti-HHV-8 antibody titers (≥1:51,200) in black, HIV-1 negative South African cancer patients: a case control study
94. Kaposi's Sarcoma-Associated Herpesvirus Cytotoxic T Lymphocytes Recognize and Target Darwinian Positively Selected Autologous K1 Epitopes
95. Identification of Kaposi's Sarcoma-Associated Herpesvirus (KSHV)-Specific Cytotoxic T-Lymphocyte Epitopes and Evaluation of Reconstitution of KSHV-Specific Responses in Human Immunodeficiency Virus Type 1-Infected Patients Receiving Highly Active Antiretroviral Therapy
96. Characterization of Monoclonal Antibodies Raised against the Latent Nuclear Antigen of Human Herpesvirus 8
97. ASSOCIATION BETWEEN HHV8, HIV, CANCER AND SELECTED RISK FACTORS IN SOUTH AFRICA
98. Risk factors for Kaposi's sarcoma: A case-control study of HIV-seronegative people in Uganda.
99. The sero-epidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in adults with cancer in Uganda.
100. Viral Coinfections among African Children Infected with Human Immunodeficiency Virus Type 1.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.